Annual revenue:
$167.13M+$35.82M(+27.28%)Summary
- As of today (September 14, 2025), LGND annual revenue is $167.13 million, with the most recent change of +$35.82 million (+27.28%) on December 31, 2024.
- During the last 3 years, LGND annual revenue has fallen by -$74.41 million (-30.81%).
- LGND annual revenue is now -33.53% below its all-time high of $251.45 million, reached on December 31, 2018.
Performance
LGND Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$47.63M+$2.29M(+5.06%)Summary
- As of today (September 14, 2025), LGND quarterly revenue is $47.63 million, with the most recent change of +$2.29 million (+5.06%) on June 30, 2025.
- Over the past year, LGND quarterly revenue has increased by +$6.10 million (+14.68%).
- LGND quarterly revenue is now -47.11% below its all-time high of $90.04 million, reached on June 30, 2018.
Performance
LGND Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$187.58M+$6.10M(+3.36%)Summary
- As of today (September 14, 2025), LGND TTM revenue is $187.58 million, with the most recent change of +$6.10 million (+3.36%) on June 30, 2025.
- Over the past year, LGND TTM revenue has increased by +$54.11 million (+40.54%).
- LGND TTM revenue is now -31.70% below its all-time high of $274.65 million, reached on September 30, 2021.
Performance
LGND TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
LGND Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.3% | +14.7% | +40.5% |
| 3 y3 years | -30.8% | -5.0% | -9.8% |
| 5 y5 years | +39.0% | +15.0% | +48.4% |
LGND Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.8% | +27.3% | -19.6% | +80.6% | -9.8% | +58.5% |
| 5 y | 5-year | -30.8% | +39.0% | -43.8% | +80.6% | -31.7% | +58.5% |
| alltime | all time | -33.5% | +2740.7% | -47.1% | >+9999.0% | -31.7% | +8055.8% |
LGND Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $47.63M(+5.1%) | $187.58M(+3.4%) |
| Mar 2025 | - | $45.33M(+5.9%) | $181.49M(+8.6%) |
| Dec 2024 | $167.13M(+27.3%) | $42.81M(-17.4%) | $167.13M(+9.7%) |
| Sep 2024 | - | $51.81M(+24.8%) | $152.42M(+14.2%) |
| Jun 2024 | - | $41.53M(+34.1%) | $133.48M(+12.8%) |
| Mar 2024 | - | $30.98M(+10.2%) | $118.31M(-9.9%) |
| Dec 2023 | $131.31M(-33.1%) | $28.10M(-14.5%) | $131.31M(-14.5%) |
| Sep 2023 | - | $32.87M(+24.7%) | $153.59M(-14.6%) |
| Jun 2023 | - | $26.37M(-40.0%) | $179.95M(-11.7%) |
| Mar 2023 | - | $43.98M(-12.7%) | $203.71M(+3.8%) |
| Dec 2022 | $196.25M(-18.8%) | $50.38M(-14.9%) | $196.25M(-3.0%) |
| Sep 2022 | - | $59.22M(+18.1%) | $202.27M(-2.7%) |
| Jun 2022 | - | $50.13M(+37.3%) | $207.88M(-14.3%) |
| Mar 2022 | - | $36.52M(-35.3%) | $242.43M(-7.1%) |
| Dec 2021 | $241.54M(+29.6%) | $56.40M(-13.0%) | $261.06M(-4.9%) |
| Sep 2021 | - | $64.83M(-23.4%) | $274.65M(+9.1%) |
| Jun 2021 | - | $84.67M(+53.5%) | $251.66M(+20.8%) |
| Mar 2021 | - | $55.15M(-21.2%) | $208.41M(+11.8%) |
| Dec 2020 | $186.42M(+55.0%) | $69.99M(+67.2%) | $186.42M(+30.0%) |
| Sep 2020 | - | $41.85M(+1.0%) | $143.43M(+13.5%) |
| Jun 2020 | - | $41.42M(+24.9%) | $126.39M(+14.9%) |
| Mar 2020 | - | $33.16M(+22.8%) | $109.96M(-8.6%) |
| Dec 2019 | $120.28M(-52.2%) | $27.00M(+8.8%) | $120.28M(-21.3%) |
| Sep 2019 | - | $24.81M(-0.7%) | $152.87M(-12.0%) |
| Jun 2019 | - | $24.99M(-42.5%) | $173.72M(-27.2%) |
| Mar 2019 | - | $43.48M(-27.0%) | $238.78M(-5.0%) |
| Dec 2018 | $251.45M(+78.2%) | $59.59M(+30.5%) | $251.45M(+3.8%) |
| Sep 2018 | - | $45.66M(-49.3%) | $242.33M(+5.3%) |
| Jun 2018 | - | $90.04M(+60.3%) | $230.04M(+36.9%) |
| Mar 2018 | - | $56.16M(+11.3%) | $167.99M(+19.1%) |
| Dec 2017 | $141.10M(+29.5%) | $50.46M(+51.2%) | $141.10M(+9.5%) |
| Sep 2017 | - | $33.38M(+19.2%) | $128.82M(+10.0%) |
| Jun 2017 | - | $28.00M(-4.3%) | $117.07M(+7.8%) |
| Mar 2017 | - | $29.27M(-23.4%) | $108.59M(-0.3%) |
| Dec 2016 | $108.97M(+51.5%) | $38.19M(+76.6%) | $108.97M(+18.5%) |
| Sep 2016 | - | $21.62M(+10.7%) | $91.98M(+4.4%) |
| Jun 2016 | - | $19.52M(-34.2%) | $88.06M(+1.3%) |
| Mar 2016 | - | $29.65M(+39.9%) | $86.96M(+20.9%) |
| Dec 2015 | $71.91M(+11.4%) | $21.19M(+19.7%) | $71.91M(-2.4%) |
| Sep 2015 | - | $17.70M(-3.9%) | $73.72M(+3.8%) |
| Jun 2015 | - | $18.42M(+26.1%) | $70.99M(+12.4%) |
| Mar 2015 | - | $14.60M(-36.5%) | $63.18M(-2.1%) |
| Dec 2014 | $64.54M(+31.8%) | $23.00M(+53.6%) | $64.54M(+14.7%) |
| Sep 2014 | - | $14.97M(+41.1%) | $56.27M(+3.6%) |
| Jun 2014 | - | $10.61M(-33.5%) | $54.31M(+1.9%) |
| Mar 2014 | - | $15.96M(+8.3%) | $53.28M(+8.8%) |
| Dec 2013 | $48.97M(+56.0%) | $14.74M(+13.3%) | $48.97M(+2.3%) |
| Sep 2013 | - | $13.01M(+35.8%) | $47.87M(+16.1%) |
| Jun 2013 | - | $9.58M(-17.8%) | $41.24M(+10.3%) |
| Mar 2013 | - | $11.65M(-14.6%) | $37.40M(+19.2%) |
| Dec 2012 | $31.39M(+4.5%) | $13.63M(+113.9%) | $31.39M(+2.3%) |
| Sep 2012 | - | $6.38M(+11.0%) | $30.69M(+2.1%) |
| Jun 2012 | - | $5.74M(+1.9%) | $30.05M(-5.4%) |
| Mar 2012 | - | $5.64M(-56.4%) | $31.78M(+5.8%) |
| Dec 2011 | $30.04M(+27.6%) | $12.94M(+125.3%) | $30.04M(+42.8%) |
| Sep 2011 | - | $5.74M(-23.1%) | $21.04M(-8.9%) |
| Jun 2011 | - | $7.46M(+91.6%) | $23.10M(+7.6%) |
| Mar 2011 | - | $3.90M(-1.1%) | $21.48M(-8.8%) |
| Dec 2010 | $23.54M(-39.6%) | $3.94M(-49.5%) | $23.54M(-29.9%) |
| Sep 2010 | - | $7.80M(+33.6%) | $33.57M(-0.3%) |
| Jun 2010 | - | $5.84M(-2.0%) | $33.67M(-5.0%) |
| Mar 2010 | - | $5.96M(-57.4%) | $35.43M(-9.0%) |
| Dec 2009 | $38.94M | $13.97M(+76.9%) | $38.94M(+4.2%) |
| Sep 2009 | - | $7.90M(+4.0%) | $37.35M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | $7.59M(-19.8%) | $34.70M(+8.7%) |
| Mar 2009 | - | $9.47M(-23.6%) | $31.91M(+16.8%) |
| Dec 2008 | $27.32M(+111.8%) | $12.39M(+136.1%) | $27.32M(+32.0%) |
| Sep 2008 | - | $5.25M(+9.2%) | $20.70M(-1.1%) |
| Jun 2008 | - | $4.80M(-1.4%) | $20.93M(+19.4%) |
| Mar 2008 | - | $4.87M(-15.5%) | $17.53M(+36.0%) |
| Dec 2007 | $12.89M(-90.9%) | $5.77M(+5.3%) | $12.89M(-68.7%) |
| Sep 2007 | - | $5.48M(+288.6%) | $41.25M(-43.1%) |
| Jun 2007 | - | $1.41M(+500.0%) | $72.48M(-39.4%) |
| Mar 2007 | - | $235.00K(-99.3%) | $119.52M(-29.8%) |
| Dec 2006 | $140.96M(-20.2%) | $34.13M(-7.0%) | $170.24M(-8.1%) |
| Sep 2006 | - | $36.71M(-24.2%) | $185.18M(-4.2%) |
| Jun 2006 | - | $48.45M(-4.9%) | $193.23M(+1.4%) |
| Mar 2006 | - | $50.96M(+3.8%) | $190.58M(+7.9%) |
| Dec 2005 | $176.61M(+8.0%) | $49.07M(+9.6%) | $176.61M(-9.2%) |
| Sep 2005 | - | $44.76M(-2.3%) | $194.59M(+4.3%) |
| Jun 2005 | - | $45.80M(+23.8%) | $186.61M(+7.8%) |
| Mar 2005 | - | $36.98M(-44.8%) | $173.08M(+5.9%) |
| Dec 2004 | $163.51M(+15.9%) | $67.05M(+82.3%) | $163.51M(+6.1%) |
| Sep 2004 | - | $36.77M(+13.9%) | $154.07M(+3.7%) |
| Jun 2004 | - | $32.27M(+17.7%) | $148.58M(+2.2%) |
| Mar 2004 | - | $27.41M(-52.4%) | $145.43M(+3.0%) |
| Dec 2003 | $141.14M(+46.0%) | $57.61M(+84.2%) | $141.14M(+27.3%) |
| Sep 2003 | - | $31.28M(+7.4%) | $110.85M(+5.7%) |
| Jun 2003 | - | $29.13M(+26.0%) | $104.84M(+10.5%) |
| Mar 2003 | - | $23.12M(-15.4%) | $94.88M(-1.8%) |
| Dec 2002 | $96.64M(+26.6%) | $27.32M(+8.1%) | $96.64M(+5.1%) |
| Sep 2002 | - | $25.27M(+31.8%) | $91.96M(+7.1%) |
| Jun 2002 | - | $19.17M(-23.0%) | $85.87M(+2.0%) |
| Mar 2002 | - | $24.89M(+9.9%) | $84.19M(+10.3%) |
| Dec 2001 | $76.34M(+58.7%) | $22.64M(+18.1%) | $76.34M(+13.0%) |
| Sep 2001 | - | $19.17M(+9.6%) | $67.53M(+11.8%) |
| Jun 2001 | - | $17.49M(+2.7%) | $60.43M(+12.5%) |
| Mar 2001 | - | $17.04M(+23.1%) | $53.71M(+11.1%) |
| Dec 2000 | $48.11M(+17.6%) | $13.83M(+14.6%) | $48.34M(+3.0%) |
| Sep 2000 | - | $12.07M(+12.1%) | $46.94M(+5.2%) |
| Jun 2000 | - | $10.77M(-7.7%) | $44.63M(+5.6%) |
| Mar 2000 | - | $11.67M(-6.1%) | $42.28M(+3.4%) |
| Dec 1999 | $40.90M(+131.4%) | $12.43M(+27.3%) | $40.90M(+24.9%) |
| Sep 1999 | - | $9.77M(+16.0%) | $32.74M(+21.6%) |
| Jun 1999 | - | $8.42M(-18.1%) | $26.92M(+17.6%) |
| Mar 1999 | - | $10.28M(+140.5%) | $22.89M(+29.5%) |
| Dec 1998 | $17.67M(-65.8%) | $4.27M(+8.3%) | $17.67M(-49.8%) |
| Sep 1998 | - | $3.95M(-10.0%) | $35.20M(-15.1%) |
| Jun 1998 | - | $4.39M(-13.4%) | $41.45M(-11.7%) |
| Mar 1998 | - | $5.07M(-76.8%) | $46.97M(-9.2%) |
| Dec 1997 | $51.70M(+40.3%) | $21.80M(+113.7%) | $51.70M(+30.9%) |
| Sep 1997 | - | $10.20M(+3.0%) | $39.50M(+0.3%) |
| Jun 1997 | - | $9.90M(+1.0%) | $39.40M(+3.7%) |
| Mar 1997 | - | $9.80M(+2.1%) | $38.00M(+2.7%) |
| Dec 1996 | $36.84M(+50.3%) | $9.60M(-5.0%) | $37.00M(+4.8%) |
| Sep 1996 | - | $10.10M(+18.8%) | $35.30M(+11.0%) |
| Jun 1996 | - | $8.50M(-3.4%) | $31.80M(+10.8%) |
| Mar 1996 | - | $8.80M(+11.4%) | $28.70M(+17.1%) |
| Dec 1995 | $24.52M(+84.2%) | $7.90M(+19.7%) | $24.50M(+14.5%) |
| Sep 1995 | - | $6.60M(+22.2%) | $21.40M(+15.7%) |
| Jun 1995 | - | $5.40M(+17.4%) | $18.50M(+18.6%) |
| Mar 1995 | - | $4.60M(-4.2%) | $15.60M(+17.3%) |
| Dec 1994 | $13.31M(-18.2%) | $4.80M(+29.7%) | $13.30M(+56.5%) |
| Sep 1994 | - | $3.70M(+48.0%) | $8.50M(+77.1%) |
| Jun 1994 | - | $2.50M(+8.7%) | $4.80M(+108.7%) |
| Mar 1994 | - | $2.30M | $2.30M |
| Dec 1993 | $16.26M(+176.4%) | - | - |
| Dec 1992 | $5.88M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual revenue?
- What is the all time high annual revenue for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual revenue year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly revenue?
- What is the all time high quarterly revenue for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly revenue year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM revenue?
- What is the all time high TTM revenue for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM revenue year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual revenue?
The current annual revenue of LGND is $167.13M
What is the all time high annual revenue for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual revenue is $251.45M
What is Ligand Pharmaceuticals Incorporated annual revenue year-on-year change?
Over the past year, LGND annual revenue has changed by +$35.82M (+27.28%)
What is Ligand Pharmaceuticals Incorporated quarterly revenue?
The current quarterly revenue of LGND is $47.63M
What is the all time high quarterly revenue for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly revenue is $90.04M
What is Ligand Pharmaceuticals Incorporated quarterly revenue year-on-year change?
Over the past year, LGND quarterly revenue has changed by +$6.10M (+14.68%)
What is Ligand Pharmaceuticals Incorporated TTM revenue?
The current TTM revenue of LGND is $187.58M
What is the all time high TTM revenue for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM revenue is $274.65M
What is Ligand Pharmaceuticals Incorporated TTM revenue year-on-year change?
Over the past year, LGND TTM revenue has changed by +$54.11M (+40.54%)